ICS + LAMA add‐on vs ICS dose increase
Exacerbations leading to ED visits · adults with asthma
ICS + LAMA add‐on showed no clear difference in exacerbations requiring ED visit 14 weeks compared with ICS dose increase (low certainty).
1 finding from 1 review
- Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults… 2015 · Cochrane Headline outcomes onlyOR 0.49 [0.09, 2.77]1 study · 174 participantsLow